Angiotensin II-induced mitochondrial reactive oxygen species and peroxiredoxin-3 expression in cardiac fibroblasts

Journal of Hypertension

Volumn 30, Issue 10, 2012, Pages 1986-1991

  Lijnen, Paul J ^a   Piccart, Yvette ^a   Coenen, Tamara ^a   Prihadi, John S ^a  

^a KU LEUVEN DEPARTMENT OF REHABILITATION SCIENCES   (Belgium)

Author keywords

angiotensin II; cardiac fibroblasts; mitochondria; peroxiredoxin 3; reactive oxygen species

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ANGIOTENSIN II; LOSARTAN; MESSENGER RNA; PEROXIREDOXIN 3; REACTIVE OXYGEN METABOLITE;

ANIMAL TISSUE; ARTICLE; DNA CONTENT; DNA SYNTHESIS; FIBROBLAST; HEART MITOCHONDRION; HEART MUSCLE; IN VITRO STUDY; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 84866533470     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0b013e32835726c1     Document Type: Article

References (47)

1. Touyz RM. Reactive oxygen species as mediators of calcium handling by angiotensin II in vascular physiology and pathophysiology. Antioxid Redox Signal 2005; 7:2850-2870.
2. Li PF, Dietz R, von Harsdorf R. Superoxide induces apoptosis in cardiocytes, but proliferation and expression of transforming growth factor-b1 in cardiac fibroblasts. FEBS Lett 1999; 448:206-210.
3. Tsutsui H, Kimugawa S, Matsushima S. Mitochondrial oxidative stress and dysfunction in myocardial remodeling. Cardiovasc Res 2009; 81:449-456.
4. Kang SW, Chae HZ, Seo MS, Kim K, Baines IC, Rhee SG. Mammalian peroxiredoxin isoforms can reduce hydrogen peroxide generated in response to growth factors and tumor necrosis factor-a. J Biol Chem 1998; 273:6297-6302.
5. Fatma N, Singh DP, Schinohara T, Chylack LT. Transcriptional regulation of the antioxidant protein 2 gene, a thiol-specific antioxidant, by lens epithelium-derived growth factor to protect cells from oxidative stress. J Biol Chem 2001; 276:48899-48907.
6. Fujii T, Fujii J, Taniguchi N. Augmented expression of peroxiredoxin VI in rat lung and kidney after birth implies an antioxidative role. Eur J Biochem 2001; 268:218-225.
7. Salmon M, Dedessus Le Moutier J, Wenders F, Chiarizia S, Eliaers F, Remade J, et al. Role of the PLA2-independent peroxiredoxin VI activity in the survival of immortalized fibroblasts to cytotoxic oxidative stress. FEBS Lett 2004; 557:26-32.
8. Schröder E, Brennan JP, Eaton P. Cardiac peroxiredoxins undergo complex modifications during cardiac oxidant stress. Am J Physiol 2008; 295:H425-433.
9. Rhee SG, Chae HZ, Kim K. Peroxiredoxins: a historical overview and speculative preview of novel mechanisms and emerging concepts in cell signaling. Free Radic Biol Med 2005; 38:1543-1552.
10. Ebrahimian T, Touyz RM. Thioredoxin in vascular biology: role in hypertension. Antioxid Redox Signal 2009; 10:1127-1135.
11. Watabe S, Hiroi T, Yamamoto Y, Fujioka Y, Hasegawa H, Yago N, Takahashi SY. SP-22 is a thioredoxin-dependent peroxide reductase in mitochondria. Eur J Biochem 1997; 249:52-60.
12. Murphy MP. How mitochondria produce reactive oxygen species. Biochem J 2009; 417:1-13.
13. Petrosillo G, Matera M, Moro N, Ruggiero FM, Paradies G. Mitochondrial complex I dysfunction in rat heart with aging: critical role of reactive oxygen species and cardiolipin. Free Radic Biol Med 2009; 46:88-94.
14. Bryk R, Griffin P, Nathan C. Peroxynitrite reductase activity of bacterial peroxiredoxins. Nature 2000; 407:211-215.
15. Reinartz M, Ding Z, Flögel U, Gödecke A, Schrader J. Nitrosative stress leads to protein glutathiolation, increased s-nitrosation and up-regulation of peroxiredoxins in the heart. J Biol Chem 2008; 283:17440-17449.
16. Lijnen P, Papparella I, Petrov V, Semplicini A, Fagard R. Angiotensin II-stimulated collagen production in cardiac fibroblasts is mediated by reactive oxygen species. J Hypertens 2006; 24:757-766.
17. Lijnen P, Petrov V, van Pelt J, Fagard R. Inhibition of superoxide dismutase induces collagen production in cardiac fibroblasts. Am J Hypertens 2008; 21:1129-1136.
18. Lijnen P, van Pelt J, Fagard R. Down-regulation of manganese superoxide dismutase by angiotensin II in cardiac fibroblasts. Am J Hypertens 2010; 23:1128-1135.
19. Petrov V, Fagard R, Lijnen P. Stimulation of collagen production by transforming growth factor-b1 during differentiation of cardiac fibro-blasts to myofibroblasts. Hypertension 2002; 39:258-263.
20. Petrov VV, Van Pelt JF, Verneersch JR, Van Duppen VJ, Vekemans K, Fagard RH, Lijnen PJ. TGF-b1-induced cardiac myofibroblasts are nonproliferating cells carrying DNA damages. Exp Cell Res 2008; 314:1480-1494.
21. Onorato TM, Brown PW, Morris PL. Mono-(2-ethylhexyl)phthalate increases spermatocyte mitochondrial peroxiredoxin-3 and cycloox-ygenase 2. J Androl 2008; 29:293-303.
22. Tölle A, Schlame M, Charlier N, Guthmann F, Rüstow B. Vitamin E differentially regulates the expression of peroxiredoxin-1 and-6 in alveolar type II cells. Free Radic Biol Med 2005; 38:1401-1408.
23. Andrukhiv A, Costa AD, West IC, Garlid KD. Opening mitoKATP increases superoxide generation from complex I of the electron transport chain. Am J Physiol 2006; 291:H2067-H2074.
24. Wood-Allum R, Barber SC, Kirby J, Heath P, Holden H, Mead R, et al. Impairment of mitochondrial antioxidant defence in SOD1-related motor neuron injury and amelioration by ebselen. Brain 2006; 129:1693-1709.
25. Oh YK, Lee TB, Choi CH. Antioxidant adaptation in the AML cells supersensitive to hydrogen peroxide. Biochem Biophys Res Commun 2004; 319:41-45.
26. Hattori F, Murayama N, Noshita T, Oikawa S. Mitochondrial peroxir-edoxin-3 protects hippocampal neurons from excitotoxic injury in vivo. J Neurochem 2003; 86:860-868.
27. Brixius K, Schwinger RHG, Hoyer F, Napp A, Renner R, Bölck B, et al. Isoform-specific downregulation of peroxiredoxin in human failing myocardiam. Life Sci 2007; 81:823-831.
28. Ebrahimian T, He Y, Schiffrin EL, Touyz RM. Differential regulation of thioredoxin and NAD(P)H oxidase by angiotensin II in male and female mice. J Hypertens 2007; 25:1263-1271.
29. Yamamoto M, Yang G, Hong C, Liu J, Holle E, Yu X, et al. Inhibition of endogenous thioredoxin in the heart increases oxidative stress and cardiac hypertrophy. J Clin Invest 2003; 112:1395-1405.
30. Yoshioka J, Schulze PC, Cupesi M, Sylvan JD, MacGillivray C, Gannon J, et al. Thioredoxulation of thioredoxin activity. Circulation 2004; 109:2581-2586.
31. Tanito M, Nakamura H, Kwon YW, Teratani A, Masutani H, Shioji K, et al. Enhanced oxidative stress and impaired thioredoxin expression in spontaneously hypertensive rats. Antioxid Redox Signal 2004; 6:89-97.
32. McCommis KS, McGee AM, Laughlin MH, Bowles Dk, Baines CP. Hyperclolesterolemia increases mitochondrial oxidative stress and enhances the MPT response in the porcine myocardium: beneficial effects of chronic exercise. Am J Physiol 2011; 301:R1250-1258.
33. Zhang GX, Lu XM, Kimura S, Nishiyama A. Role of mitochondria in angiotensin II-induced reactive oxygen species and mitogen-activated protein kinase activation. Cardiovasc Res 2007; 76:204-212.
34. Dai DF, Johnson SC, Villarin JJ, Chin MT, Nieves-Cintron M, Chen T, et al. Mitochondrial oxidative stress mediates angiotensin II-induced cardiac hypertrophy and Gaq overexpression-induced heart failure. Circ Res 2011; 108:837-846.
35. Ide T, Tsutsui H, Kinugawa S, Utsumi H, Kang D, Hattori N, et al. Mitochondrial electron transport complex I is a potential source of oxygen free radicals in the failing heart. Circ Res 1999; 85:357-363.
36. Dai DF, Chen T, Szeto H, Nieves-Cintron M, Kutyavin V, Santana Lf, Rabinovitch PS. Mitochondrial targeted antioxidant peptide ameliorates hypertensive cardiomyopathy. J Am Coll Cardiol 2011; 58:73-82.
37. Chang TS, Cho CS, Park S, Yu S, Kang SW, Rhee SG. Peroxiredoxin III, a mitochondrion-specific peroxidase, regulates apoptotic signaling by mitochondria. J Biol Chem 2004; 279:41975-41984.
38. Li L, Shoji W, Takano H, Nishimura N, Aoki Y, Takahashi R, et al. Increased susceptibility of MER5 (peroxiredoxin III) knockout mice to LPS-induced oxidative stress. Biochem Biophys Res Commun 2007; 355:715-721.
39. Matsushima S, Ide T, Yamato M, Matsusaka H, Hattori F, Ikeuchi M, et al. Overexpression of mitochondrial peroxiredoxin-3 prevents left ventricular remodeling and failure after myocardial infarction in mice. Circulation 2006; 113:1779-1786.
40. Chen L, Na R, Gu M, Salmon AB, Liu Y, Liang H, et al. Reduction of mitochondrial H2O2 by overexpressing peroxiredoxin 3 improves glucose tolerance in mice. Aging Cells 2008; 7:866-870.
41. Suematsu N, Tsutsui H, Wen J, Kang D, Ikeuchi M, Ide T, et al. Oxidative stress mediates tumor necrosis factor-a-induced mitochon-drial DNA damage and dysfunction in cardiac myocytes. Circulation 2003; 107:1418-1423.
42. Ide T, Tsutsui H, Hayashidani S, Kang D, Suematsu N, Nakamura K, et al. Mitochondrial DNA damage and dysfunction associated with oxidative stress in failing hearts after myocardial infarction. Circ Res 2001; 88:529-535.
43. Sawyer DB, Colucci WS. Mitochondrial oxidative stress in heart failure: 'oxygen wasting' revisited. Circ Res 2000; 86:119-120.
44. Tsutsui H, Kinugawa S, Matsushima S. Oxidative stress and mitochon-drial damage in heart failure. Circ J 2008; 72:A31-37.
45. Dhalla AK, Hill MF, Singal PK. Role of oxidative stress in transition of hypertrophy to heart failure. J Am Coll Cardiol 1996; 28:506-514.
46. Touyz RM. Reactive oxygen species, vascular oxidative stress and redox signaling in hypertension: what is the clinical significance? Hypertension 2004; 44:248-252.
47. Li PF, Dietz R, von Harsdorf R. Superoxide induces apoptosis in cardiomyocytes, but proliferation and expression of transforming growth factor-b1 in cardiac fibroblasts. FEBS Lett 1999; 448:206-210.